DK1102770T3 - Parmamagnetiske 3-,8-substituerede deuteroporphyrinderivater, farmaceutiske midler indeholdende disse, fremgangsmåde til deres fremstilling og deres anvendelse til nekrose- og infarkt-MR-imaging - Google Patents

Parmamagnetiske 3-,8-substituerede deuteroporphyrinderivater, farmaceutiske midler indeholdende disse, fremgangsmåde til deres fremstilling og deres anvendelse til nekrose- og infarkt-MR-imaging

Info

Publication number
DK1102770T3
DK1102770T3 DK99936616T DK99936616T DK1102770T3 DK 1102770 T3 DK1102770 T3 DK 1102770T3 DK 99936616 T DK99936616 T DK 99936616T DK 99936616 T DK99936616 T DK 99936616T DK 1102770 T3 DK1102770 T3 DK 1102770T3
Authority
DK
Denmark
Prior art keywords
necrosis
methods
parmamagnetic
infarct
preparation
Prior art date
Application number
DK99936616T
Other languages
Danish (da)
English (en)
Inventor
Johannes Platzek
Ulrich Niedballa
Bernd Raduechel
Hanns-Joachim Weinmann
Thomas Frenzel
Bernd Misselwitz
Wolfgang Ebert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK1102770T3 publication Critical patent/DK1102770T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK99936616T 1998-07-24 1999-07-15 Parmamagnetiske 3-,8-substituerede deuteroporphyrinderivater, farmaceutiske midler indeholdende disse, fremgangsmåde til deres fremstilling og deres anvendelse til nekrose- og infarkt-MR-imaging DK1102770T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19835082A DE19835082A1 (de) 1998-07-24 1998-07-24 Paramagnetische 3-,8-substituierte Deuteroporphyrinderivate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung für das Nekrose- und Infarkt-MR-Imaging
PCT/EP1999/005522 WO2000005235A1 (de) 1998-07-24 1999-07-15 Paramagnetische 3-,8-substituierte deuteroporphyrinderivate, diese enthaltende pharmazeutische mittel, verfahren zu ihrer herstellung und ihre verwendung für das nekrose- und infarkt-mr-imaging

Publications (1)

Publication Number Publication Date
DK1102770T3 true DK1102770T3 (da) 2003-12-01

Family

ID=7876347

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99936616T DK1102770T3 (da) 1998-07-24 1999-07-15 Parmamagnetiske 3-,8-substituerede deuteroporphyrinderivater, farmaceutiske midler indeholdende disse, fremgangsmåde til deres fremstilling og deres anvendelse til nekrose- og infarkt-MR-imaging

Country Status (11)

Country Link
EP (1) EP1102770B1 (pt)
JP (1) JP2002521384A (pt)
AT (1) ATE247659T1 (pt)
AU (1) AU5164699A (pt)
DE (2) DE19835082A1 (pt)
DK (1) DK1102770T3 (pt)
ES (1) ES2205863T3 (pt)
NO (1) NO317788B1 (pt)
PT (1) PT1102770E (pt)
TW (1) TW553941B (pt)
WO (1) WO2000005235A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482943B1 (en) 1999-04-30 2002-11-19 Slil Biomedical Corporation Quinones as disease therapies
EP1401430A4 (en) 2001-05-31 2005-10-19 Miravant Pharm Inc SUBSTITUTED PORPHYRIN AND AZAPORPHYRIN DERIVATIVES AND USE IN PHOTODYNAMIC THERAPY, RADIOIMAGING, AND MRI DIAGNOSIS
AU2003248763A1 (en) * 2002-06-28 2004-01-19 Pharmacia Corporation Methods and contrast agents useful in quantifying nitric oxide
DE10240343A1 (de) * 2002-08-27 2004-03-11 Schering Ag Peroxynitrit-Umlagerungskatalysatoren
WO2012105483A1 (ja) * 2011-01-31 2012-08-09 国立大学法人宇都宮大学 ポルフィリン型骨格を有する化合物の金属錯体の製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284647A (en) * 1988-03-18 1994-02-08 Schering Aktiengesellschaft Mesotetraphenylporphyrin complex compounds, process for their production and pharmaceutical agents containing them
US5612016A (en) * 1988-04-01 1997-03-18 Immunomedics, Inc. Conjugates of antibodies and bifunctional ligands
DE3827940A1 (de) * 1988-08-13 1990-03-01 Schering Ag 13,17-propionsaeure- und propionsaeurederivat- substituierte porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
DE4232925A1 (de) * 1992-09-28 1994-03-31 Diagnostikforschung Inst 3-,8-substituierte Deuteroporphyrinderivate, diese enthaltende pharmazeutische Mittel und Verfahren zu ihrer Herstellung
EP0758907A1 (en) * 1994-05-11 1997-02-26 Schering Aktiengesellschaft The use of porphyrin-complex or expanded porphyrin-complex compounds as localization diagnosticum for infarction or necrosis
DE19824653A1 (de) * 1998-02-25 1999-08-26 Schering Ag Nekrose-affine Verbindungen und ihre Verwendung zur Herstellung von Präparaten zur Pharmakotherapie

Also Published As

Publication number Publication date
NO317788B1 (no) 2004-12-13
NO20010392D0 (no) 2001-01-23
ATE247659T1 (de) 2003-09-15
DE19835082A1 (de) 2000-02-03
DE59906695D1 (de) 2003-09-25
NO20010392L (no) 2001-03-23
ES2205863T3 (es) 2004-05-01
EP1102770A1 (de) 2001-05-30
WO2000005235A1 (de) 2000-02-03
AU5164699A (en) 2000-02-14
EP1102770B1 (de) 2003-08-20
TW553941B (en) 2003-09-21
JP2002521384A (ja) 2002-07-16
PT1102770E (pt) 2004-01-30

Similar Documents

Publication Publication Date Title
Albrand et al. The use of transferred nuclear Overhauser effects in the study of the conformations of small molecules bound to proteins
WO2000030688A3 (en) Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as mri contrast agents
ES2087938T3 (es) Uso de complejos quelatos.
DK0874645T3 (da) Perflouralkylholdige metalkomplekser og deres anvendelse i NMR-diagnostik
Mims et al. Measurement of 14N superhyperfine frequencies in stellacyanin by an electron spin echo method.
Xia et al. Clean STD‐NMR spectrum for improved detection of ligand‐protein interactions at low concentration of protein
DK1102770T3 (da) Parmamagnetiske 3-,8-substituerede deuteroporphyrinderivater, farmaceutiske midler indeholdende disse, fremgangsmåde til deres fremstilling og deres anvendelse til nekrose- og infarkt-MR-imaging
BR9508435A (pt) Quelentes macrocíclicos seus quelatos e usos dos mesmos no campo diagnóstico
Rizzi et al. Structure and single crystal EPR study of Cu (II)(l-threonine) 2· H2O
Yamamoto et al. NMR investigation of the heme electronic structure in deoxymyoglobin possessing a fluorinated heme
Krishnamoorthi et al. A 1H NMR comparison of the met-cyano complexes of elephant and sperm whale myoglobin. Assignment of labile proton resonances in the heme cavity and determination of the distal glutamine orientation from relaxation data.
Yamamoto et al. 19 F NMR study of protein-induced rhombic perturbations on the electronic structure of the active site of myoglobin
de la Fuente et al. EPR study of the 1: 1 complexes of chromium (III) and copper (II) with 5′-GMP and 5′-CMP
Pezeshk et al. Drug-metal interactions: spectroscopic studies of copper hydantoin complexes
ATE312837T1 (de) Makrocyclische chelatbildner für metallopharmazeutika